+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Japan Non-Invasive Aesthetic Treatment Market Outlook 2025

  • PDF Icon

    Report

  • 200 Pages
  • July 2025
  • Region: Japan
  • Renub Research
  • ID: 6116526
The Japan Non-invasive Aesthetic Treatment Market is anticipated to grow from US$ 3.45 billion in 2024 to US$ 9.66 billion in 2033, expanding at a CAGR of 12.11% from 2025 to 2033. Growth in the market comes from increasing consciousness towards beauty, advancements in technology, and a growing demand for minimally invasive aesthetic treatments in Japan.

Japan Non-invasive Aesthetic Treatment Market Outlook

Non-surgical aesthetic treatments are cosmetic procedures that improve looks without surgery. Examples of such treatments include Botox, dermal fillers, laser treatments, chemical peels, and body contouring with technologies like ultrasound and radiofrequency. In Japan, such treatments have become extremely popular because of cultural demands for natural-looking, subtle improvements and low downtime.

Given a high focus on anti-aging and skincare solutions, Japanese consumers, particularly working professionals and women, are on the lookout for these treatments in order to preserve youthful and delicate looks. Clinics in Japan provide sophisticated non-invasive treatments, which align with Japan's focus on quality healthcare and innovation. The aging demographic and heightened awareness regarding aesthetics also lead to expansion in the market. With advancing safety and efficacy, non-invasive treatments are increasingly becoming popular across the globe, establishing them as the standard in Japan's beauty and wellness market.

Market Growth Drivers in Japan Non-invasive Aesthetic Treatment Market

Growing Aging Population

The aging population of Japan is a key driver of growth for non-invasive aesthetic treatments. Having one of the highest life expectancies globally, numerous Japanese consumers desire subtle anti-aging treatments to preserve youthful looks. Non-surgical treatments provide successful results with minimal downtime, which makes them attractive to older age groups. Botulinum toxin, fillers, and laser treatments are used to treat wrinkles and fine lines, which are preferred by this age group to pursue beauty. The population of individuals aged 65 or more in Japan reached a record 36.25 million this year, government statistics reported, as the nation struggled with one of the world's fastest-ageing populations. Although the overall population in the country is decreasing, the population aged 65 and older has increased to 29.3% of the population, the largest proportion in any nation, as reported by the Statistics Bureau of the Ministry of Internal Affairs and Communications.

Rising Demand for Minimally Invasive Solutions

Japanese consumers would like treatments that offer natural results with minimal risk and little downtime. Non-invasive aesthetic treatments satisfy this demand well. Techs such as lasers, radiofrequency, and injectables are in line with consumer demand for quick, effective, and safe treatments. This has created an increasing clinic services and innovations aimed at minimally invasive procedures, driving market growth. For example, Abbott labs in August 2022 introduced a TactiFlex SE irrigation catheter, a radiofrequency (RF) ablation catheter featuring a slit tip electrode with contact force technology, in Japan. In March 2022, Shockwave Medical's Shockwave C² Coronary Intravascular Lithotripsy (IVL) Catheter was approved by Japan's PMDA.

Growth in Medical Tourism and Medspa Culture

Japan's high-reputation medical technologies and high-quality medical care have fueled medical tourism, particularly for aesthetic procedures. Furthermore, growth in medspa culture in city centers has urged consumers to seek out cosmetic enhancements in a spa-like setting, relaxing. The trend contributes to consistent growth in the non-invasive aesthetic market. Centering on medical tourism, the medical stay visas issued have risen from 1,653 in 2019 (before the pandemic) to 2,295 in 2023, reflecting sustained high demand for quality Japanese medical care. According to JTB, medical inbound reservations in 2023 more than doubled compared to the previous year, and this trend is expected to continue into 2024. Notably, there has been a significant increase in medical visits from Asian countries, especially China. Before the pandemic, about 70% of medical stay visas were issued to Chinese nationals.

Challenges in the Japan Non-invasive Aesthetic Treatment Market

High Treatment Costs

Japanese non-invasive aesthetic procedures tend to be more expensive than those in neighboring Asian markets. This makes them inaccessible to young populations and middle-income segments. High prices are fueled by the latest technologies, specialist skills, and rigorous regulatory adherence. While the affluent continue to support these treatments, price becomes an obstacle to increased take-up.

Regulatory and Safety Concerns

Japan has rigorous controls to guarantee the safety and effectiveness of aesthetic interventions. This protects the consumer but also makes it difficult for new technologies and procedures to enter the market. Regulator barriers to entry may hinder expansion into the market, and fear of side effects and safety measures may discourage prospective consumers from adopting newer forms of treatments.

Japan Non-invasive Aesthetic Botulinum Toxin Market

The botulinum toxin category is a major contributor to Japan's non-invasive aesthetic sector. It is used extensively for wrinkle reduction, slimming, and correcting fine lines, especially among the aging group. The natural and subtle outcomes that can be achieved with botulinum toxin treatments are preferred by Japanese consumers, hence enhancing demand. Urban cities' clinics experience steady patient demand because of the minimally invasive approach and quick recovery of this procedure.

Japan Non-invasive Aesthetic Hyaluronic Acid Market

Hyaluronic acid fillers are highly sought in Japan for rejuvenation of the face, hydration, and restoring volume. They are attractive for people seeking non-surgical treatments to attain youthful looks. They are particularly preferred for enhancing lips and restoring cheek volume. The safety, reversibility, and low downtime of hyaluronic acid injectable products further contribute to their popularity in the Japanese market.

Japan Non-invasive Aesthetic Treatment Chemical Peel Market

Chemical peels are also popular in Japan for resurfacing the skin, treating acne, and enhancing pigmentation. With Japanese consumers valuing clear and even-toned and smooth skin, professional chemical peel treatments continue to see consistent demand. The treatments are a staple in dermatology clinics and medspas, which appeal to consumers seeking effective yet non-surgical methods of rejuvenating the skin.

Japan Non-invasive Aesthetic Treatment Hair Removal Market

Laser hair removal is increasingly popular in Japan because of aesthetic desires for hair-free, smooth skin. Advanced lasers accommodate multiple skin types with a minimal degree of discomfort and are very popular as a result. Clinics and medspas market the treatments due to their long-term effects, safety, and ease, further fueling demand among the country's urban dwellers.

Japan Male Non-invasive Aesthetic Treatment Market

Non-surgical cosmetic treatments are increasingly appealing to Japanese male consumers. Growing cultural acceptability of men getting cosmetic treatments to look young and well-coiffed is on the rise. Trending among men are botulinum toxin, hair removal, and skin rejuvenation treatments. Clinics are altering their services according to the men's specific needs, which is fueling this growing market segment.

Japan Medspa Non-invasive Aesthetic Treatment Market

Japanese medspas combine sophisticated medical technology with luxurious spa experiences, providing non-invasive aesthetic treatments in a relaxing setting. The centers are most attractive to women requiring anti-aging therapies, skin rejuvenation, and body reshaping. The focus on the medspa trend is on wellness and beauty combined, which renders it the first choice for a broad range of people.

Tokyo Non-invasive Aesthetic Treatment Market

Tokyo dominates Japan's non-invasive aesthetic treatment market, driven by its wealthier population, medical tourism, and sophisticated clinic infrastructure. The people in this region have a strong focus on beauty and wellness, generating high demand for treatments such as Botox, fillers, and laser treatments. The competitive nature of the Tokyo market promotes innovation and the use of new technologies in aesthetic treatments.

Aichi Non-invasive Aesthetic Treatment Market

Aichi, where large cities such as Nagoya are located, has experienced growing interest in non-invasive beauty treatments. Growing disposable incomes and knowledge of beauty innovation support market expansion. Clinics in the prefecture provide numerous services, ranging from skin rejuvenation to wrinkle elimination and hair removal, for both women and men.

Shizuoka Non-invasive Aesthetic Treatment Market

Shizuoka's non-surgical aesthetic market is developing consistently as neighborhood clinics branch out to supply state-of-the-art treatments such as laser therapies and injectables. Drivers are the aging populace of the area and rising aesthetic awareness. Customers are keen on treatments with minimal downtime, and clinics are more interested in providing natural, youthful outcomes that fit Japanese beauty ideals.

Market Segmentation

Procedure

Injectables

  • Botulinum Toxin
  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-Lactic Acid

Facial Rejuvenation

  • Photo Rejuvenation
  • Chemical peel
  • Micro Ablative Resurfacing
  • Full field Ablative

Others

  • Hair Removal
  • Non Surgical Fat Reduction

Gender

  • Male
  • Female

End User

  • Hospital/surgery centre
  • Medspa
  • Traditional Spa
  • HCP Owned Clinic

Top 10 City

  • Tokyo
  • Kansai
  • Aichi
  • Kanagawa
  • Saitama
  • Hyogo
  • Chiba
  • Hokkaido
  • Fukuoka
  • Shizuoka

Key Players Analysis (Overviews, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis)

  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • Abbvie Inc.
  • Sisram Medical Ltd.
  • Galderma S.A.
  • Sientra Inc.
  • Revance Therapeutics Inc.

Table of Contents

1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Japan Non-invasive Aesthetic Treatment Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Procedure
6.2 By Gender
6.3 By End User
6.4 By City
7. Procedure
7.1 Injectables
7.1.1 Botulinum Toxin
7.1.1.1 Market Analysis
7.1.1.2 Market Size & Forecast
7.1.2 Hyaluronic Acid
7.1.2.1 Market Analysis
7.1.2.2 Market Size & Forecast
7.1.3 Calcium Hydroxylapatite
7.1.3.1 Market Analysis
7.1.3.2 Market Size & Forecast
7.1.4 Poly-L-Lactic Acid
7.1.4.1 Market Analysis
7.1.4.2 Market Size & Forecast
7.2 Facial Rejuvenation
7.2.1 Photo Rejuvenation
7.2.1.1 Market Analysis
7.2.1.2 Market Size & Forecast
7.2.2 Chemical peel
7.2.2.1 Market Analysis
7.2.2.2 Market Size & Forecast
7.2.3 Micro Ablative Resurfacing
7.2.3.1 Market Analysis
7.2.3.2 Market Size & Forecast
7.2.4 Full field Ablative
7.2.4.1 Market Analysis
7.2.4.2 Market Size & Forecast
7.3 Others
7.3.1 Hair Removal
7.3.1.1 Market Analysis
7.3.1.2 Market Size & Forecast
7.3.2 Non Surgical Fat Reduction
7.3.2.1 Market Analysis
7.3.2.2 Market Size & Forecast
8. Gender
8.1 Male
8.1.1.1 Market Analysis
8.1.1.2 Market Size & Forecast
8.2 Female
8.2.1.1 Market Analysis
8.2.1.2 Market Size & Forecast
9. End User
9.1 Hospital/surgery centre
9.1.1.1 Market Analysis
9.1.1.2 Market Size & Forecast
9.2 Medspa
9.2.1.1 Market Analysis
9.2.1.2 Market Size & Forecast
9.3 Traditional Spa
9.3.1.1 Market Analysis
9.3.1.2 Market Size & Forecast
9.4 HCP Owned Clinic
9.4.1 Market Analysis
9.4.2 Market Size & Forecast
10. Top 10 City
10.1 Tokyo
10.1.1 Market Analysis
10.1.2 Market Size & Forecast
10.2 Kansai
10.2.1 Market Analysis
10.2.2 Market Size & Forecast
10.3 Aichi
10.3.1 Market Analysis
10.3.2 Market Size & Forecast
10.4 Kanagawa
10.4.1 Market Analysis
10.4.2 Market Size & Forecast
10.5 Saitama
10.5.1 Market Analysis
10.5.2 Market Size & Forecast
10.6 Hyogo
10.6.1 Market Analysis
10.6.2 Market Size & Forecast
10.7 Chiba
10.7.1 Market Analysis
10.7.2 Market Size & Forecast
10.8 Hokkaido
10.8.1 Market Analysis
10.8.2 Market Size & Forecast
10.9 Fukuoka
10.9.1 Market Analysis
10.9.2 Market Size & Forecast
10.10 Shizuoka
10.10.1 Market Analysis
10.10.2 Market Size & Forecast
11. Value Chain Analysis
12. Porter's Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Competition
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threats
14. Pricing Benchmark Analysis
14.1 Johnson & Johnson
14.2 Bausch Health Companies Inc.
14.3 Cutera Inc.
14.4 Abbvie Inc.
14.5 Sisram Medical Ltd.
14.6 Galderma S.A.
14.7 Sientra Inc.
14.8 Revance Therapeutics Inc.
15. Key Players Analysis
15.1 Johnson & Johnson
15.1.1 Overviews
15.1.2 Key Person
15.1.3 Recent Developments
15.1.4 SWOT Analysis
15.1.5 Revenue Analysis
15.2 Bausch Health Companies Inc.
15.2.1 Overviews
15.2.2 Key Person
15.2.3 Recent Developments
15.2.4 SWOT Analysis
15.2.5 Revenue Analysis
15.3 Cutera Inc.
15.3.1 Overviews
15.3.2 Key Person
15.3.3 Recent Developments
15.3.4 SWOT Analysis
15.3.5 Revenue Analysis
15.4 Abbvie Inc.
15.4.1 Overviews
15.4.2 Key Person
15.4.3 Recent Developments
15.4.4 SWOT Analysis
15.4.5 Revenue Analysis
15.5 Sisram Medical Ltd.
15.5.1 Overviews
15.5.2 Key Person
15.5.3 Recent Developments
15.5.4 SWOT Analysis
15.5.5 Revenue Analysis
15.6 Galderma S.A.
15.6.1 Overviews
15.6.2 Key Person
15.6.3 Recent Developments
15.6.4 SWOT Analysis
15.6.5 Revenue Analysis
15.7 Sientra Inc.
15.7.1 Overviews
15.7.2 Key Person
15.7.3 Recent Developments
15.7.4 SWOT Analysis
15.7.5 Revenue Analysis
15.8 Revance Therapeutics Inc.
15.8.1 Overviews
15.8.2 Key Person
15.8.3 Recent Developments
15.8.4 SWOT Analysis
15.8.5 Revenue Analysis

Companies Mentioned

The major companies profiled in this Japan Non-Invasive Aesthetic Treatment market report include:
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • Abbvie Inc.
  • Sisram Medical Ltd.
  • Galderma S.A.
  • Sientra Inc.
  • Revance Therapeutics Inc.

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information